Skip to main content
Professional Technical IVT

Brugada syndrome

Pronunciation: broo-GAH-dah

An inherited channelopathy characterized by distinctive ECG patterns and increased risk of sudden cardiac death from ventricular arrhythmias.

Full Definition

Brugada syndrome is an inherited cardiac channelopathy caused by mutations in genes encoding cardiac sodium channels, most commonly SCN5A. It is characterized by a distinctive ECG pattern featuring coved-type ST elevation in leads V1-V3, often unmasked by sodium channel blockers like procainamide or flecainide. Patients are at increased risk for polymorphic ventricular tachycardia and sudden cardiac death, particularly during sleep or fever. The syndrome is more prevalent in Southeast Asian populations and young males. Management includes avoiding certain medications, fever control, and ICD implantation in high-risk patients.

Usage

Usage note: Named after the Brugada brothers who first described the syndrome; distinguish between Brugada pattern (ECG finding) and Brugada syndrome (clinical diagnosis).

In Context

  • "The procainamide challenge test unmasked a type 1 Brugada pattern, confirming the diagnosis of Brugada syndrome." — Diagnostic test report
  • "Family screening revealed Brugada syndrome in the proband's asymptomatic brother." — Genetic counseling report

Also known as

Brugada pattern Brugada ECG

Don't confuse with

early repolarization syndrome right bundle branch block

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON